Genus PLC
LSE:GNS

Watchlist Manager
Genus PLC Logo
Genus PLC
LSE:GNS
Watchlist
Price: 2 585 GBX -1.34%
Market Cap: 1.7B GBX

Genus PLC
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Genus PLC
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Genus PLC
LSE:GNS
Revenue
£672.8m
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
5%
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Revenue
$28.3m
CAGR 3-Years
23%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Revenue
£310.2m
CAGR 3-Years
127%
CAGR 5-Years
65%
CAGR 10-Years
N/A
Avacta Group PLC
LSE:AVCT
Revenue
-£11.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Oxford BioMedica PLC
LSE:OXB
Revenue
£151.2m
CAGR 3-Years
6%
CAGR 5-Years
18%
CAGR 10-Years
28%
No Stocks Found

Genus PLC
Glance View

Market Cap
1.7B GBX
Industry
Biotechnology

Amidst the rolling countryside of Britain, Genus PLC has quietly but profoundly reshaped the agricultural landscape since its formation. With roots tracing back to the British government's Milk Marketing Board, Genus blossomed into an influential player at the intersection of biotechnology and farming. This was not by chance, but through a strategic evolution into a global pioneer in animal genetics. At the heart of their operations, Genus enhances animal breeding by leveraging cutting-edge science, particularly the technology of selective breeding and genetics. They focus primarily on two types of livestock: bovine (cattle) and porcine (pigs), catering to agricultural sectors worldwide. Essentially, through their subsidiaries—ABS Global, focusing on cattle, and PIC, specializing in pigs—the company maximizes genetic improvements, aiding farmers in producing leaner, more disease-resistant, and ultimately more productive livestock. The business model of Genus PLC revolves around the intricate science of animal genetics and the commercial viability it crafts from this foundation. By developing genetically superior livestock, they provide a distinct competitive advantage to farmers who seek more yield with less resource input. The company harnesses sophisticated techniques like genomics and advanced biotechnologies, including gene editing, to achieve these outcomes. With each genetic line licensed, Genus receives a license fee, ensuring a steady stream of revenue. Additionally, sales channels are bolstered by continuous consultative partnerships with farmers to enhance productivity, cementing a cycle of value that perpetuates mutual growth. By marrying science with agricultural prosperity, Genus PLC remains a vanguard in a field where innovation is as essential as the soil itself.

GNS Intrinsic Value
HIDDEN
Show

See Also

What is Genus PLC's Revenue?
Revenue
672.8m GBP

Based on the financial report for Jun 30, 2025, Genus PLC's Revenue amounts to 672.8m GBP.

What is Genus PLC's Revenue growth rate?
Revenue CAGR 10Y
5%

Over the last year, the Revenue growth was 1%. The average annual Revenue growth rates for Genus PLC have been 4% over the past three years , 4% over the past five years , and 5% over the past ten years .

Back to Top